Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News EXACT Sciences Corporation EXAS

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence... see more

Current News (NDAQ:EXAS)

Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Business Wire 11 days ago

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Business Wire 12 days ago

Exact Sciences Stockholders Approve Acquisition by Abbott

Business Wire February 20, 2026

Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

Business Wire February 13, 2026

Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders

GlobeNewswire February 9, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq - EXAS), Semrush Holdings, Inc. (NYSE - SEMR)

GlobeNewswire February 9, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote-EXAS, SNDA, FSUN, and TBN

GlobeNewswire February 9, 2026

Halper Sadeh LLC is Investigating SKYT, EXAS, GORO, MOVE on Behalf of Shareholders

GlobeNewswire February 3, 2026

Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests

Business Wire February 3, 2026

Bullboard Posts (NDAQ:EXAS)

RE:Szls will eat Exas’ lunch

Can you imagine what the stock price would be if we were 2nd or 3rd?
IainCaimbeul - April 4, 2022

Szls will eat Exas’ lunch

First in liquid biopsy. Exas is years behind. 
Mykndrsn - June 19, 2021

RE:Looks like szls could be a real threat

Recognition will come to szls soon enough.
LeoSeducer67 - October 27, 2020

Looks like szls could be a real threat

To Exas  .coming soon 11 cancers detected with single drop of blood .No need to handle poop .
Choosesisely777 - October 12, 2019

​StageZero Life Sciences Enters European Market

StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million. Read...
FacBine - October 11, 2019

RE:RE:SZLS

Are you invested here SGordony???? I didn't think so, cause this is not a penny stock :)))))))) go play with your peny....:))))))))))...
FacBine - September 25, 2019

Podcasts